Global Allergy Immunotherapy Market: Size, Trends & Forecasts (2016-2020)

Global Allergy Immunotherapy Market: Size, Trends & Forecasts (2016-2020)

Scope of the Report

The report titled “Global Allergy Immunotherapy Market: Size, Trends & Forecasts (2016-2020)”, provides an in-depth analysis of the global allergy immunotherapy market by value, by methods of administration, by region, etc.

The report provides a regional analysis of the allergy immunotherapy market, including the following regions: the US, Europe and Rest of the World.

The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global allergy immunotherapy market has also been forecasted for the period 2016-2020, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

The key players of the allergy immunotherapy market ALK-Abello, Allergy Therapeutics, Merck Group and Stallergenes, who are also profiled with their financial information and respective business strategies.

Country Coverage

Europe
Rest of the World
US

Company Coverage

Allergy Therapeutics plc
ALK-Abello
Merck Group
Stallergenes

Executive Summary

Allergy refers to a condition in which the immune system abnormally reacts to the foreign substance. The foreign substance could be in the form of particular food, pollen, pets, metals, fur, dust, etc. to which the body becomes hypersensitive when comes into contact. The foreign substance that triggers the hypersensitive response in the body is known as an allergen. Generally, most substances that cause allergies are normally harmless to the human body and have no effect on the vast majority of people that are not allergic. Allergy is not a disease, it is a mere over-reaction of body to the foreign substance that is not harmful. To diagnose an allergy skin test, blood test and allergy component tests are undertaken. Allergies are generally seasonal and perennial in nature.

The global allergy immunotherapy market has increased at a significant CAGR during the years 2009-2015 and projections are made that the market would rise in the next four years i.e. 2016-2020 tremendously. The allergy immunotherapy market is expected to increase due to growth in healthcare expenditure, rising incidence of chronic diseases and increasing global pollution, etc. Yet the market faces some challenges such as, lack of treatment awareness, lack of investor confidence, anaphylaxia, huge treatment costs, etc.


1. Executive Summary
2. Introduction
2.1 Allergy
Table 1: Mechanism of Allergy
2.2 History of Allergy
2.3 Diagnosis of Allergy
Table 2: Diagnosis of Allergy
2.4 Nature of Allergy
Table 3: Nature of Allergy
2.5 Types of Allergy by Allergens
Table 4: Types of Allergy
2.6 Types of Allergens
Table 5: Types of Allergens
2.7 Prevention of Allergies
2.8 Allergy Immunotherapy: An Overview
2.8.1 Types of Immunotherapy
Table 6: Types of Immunotherapy
2.8.2 Mechanism of Immunotherapy
2.8.3 Immunotherapy by Methods of Administration
Table 7: Immunotherapy by Methods of Administration
3. Global Market Analysis
3.1 Global Allergy Immunotherapy Market: An Analysis
3.1.1 Global Allergy Immunotherapy Market by Value
Table 8: Global Allergy Immunotherapy Market by Value; 2009-2015 (US$ Billion)
Table 9: Global Allergy Immunotherapy Market by Value; 2016-2020 (US$ Billion)
3.1.2 Global Allergy Immunotherapy Market by Geography
Table 10: Global Allergy Immunotherapy Market by Geography; 2015 (Percentage, %)
3.1.3 Global Allergy Immunotherapy Market by Method of Administration
Table 11: Global Allergy Immunotherapy Market by Method of Administration; 2015 (Percentage, %)
3.2 Global Allergy Immunotherapy Market: Methods of Administration Analysis
3.2.1 Global Subcutaneous Immunotherapy Market by Value
Table 12: Global Subcutaneous Immunotherapy Market by Value; 2009-2015 (US$ Million)
Table 13: Global Subcutaneous Immunotherapy Market by Value; 2016-2020 (US$ Million)
3.2.2 Global Sublingual Immunotherapy Solution Market by Value
Table 14: Global Sublingual Immunotherapy Solution Market by Value; 2009-2015 (US$ Million)
Table 15: Global Sublingual Immunotherapy Solution Market by Value; 2016-2020 (US$ Million)
3.2.3 Global Sublingual Immunotherapy-Tablet Market by Value
Table 16: Global Sublingual Immunotherapy-Tablet Market by Value; 2009-2015 (US$ Million)
Table 17: Global Sublingual Immunotherapy-Tablet Market by Value; 2016-2020 (US$ Million)
4. Regional Market Analysis
4.1 Europe Allergy Immunotherapy Market: An Analysis
4.1.1 Europe Allergy Immunotherapy Market by Value
Table 18: Europe Allergy Immunotherapy Market by Value; 2009-2015 (US$ Million)
4.1.2 Europe Allergy Immunotherapy Market by Method of Administration
Table 19: Europe Allergy Immunotherapy Market by Method of Administration; 2014 (Percentage, %)
4.1.3 Europe Allergy Immunotherapy Market by Regional Distribution
Table 20: Europe Allergy Immunotherapy Market by Regional Distribution; 2014 (Percentage, %)
4.2 Rest of the World Allergy Immunotherapy Market: An Analysis
4.2.1 Rest of the World Allergy Immunotherapy Market by Value
Table 21: Rest of the World Allergy Immunotherapy Market by Value; 2009-2015 (US$ Million)
4.3 US Allergy Immunotherapy Market: An Analysis
4.3.1 US Allergy Immunotherapy Market by Value
Table 22: US Allergy Immunotherapy Market by Value; 2009-2015 (US$ Million)
4.3.2 US Allergy Immunotherapy Market by Method of Administration
Table 23: US Allergy Immunotherapy Market by Method of Administration; 2014 (Percentage, %)
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Increasing Global Population with Chronic Diseases
Table 24: Global Population with Chronic Diseases; 2009-2014 (Million)
5.1.2 Rising Global Healthcare Expenditure
Table 25: Global Healthcare Expenditure; 2009-2014 (US$ Trillion)
5.1.3 Increasing Pollution Worldwide
Table 26: Global Greenhouse Gas Emissions by Gases; 2014(Percentage, %)
5.1.4 Increased Use of Fertilizers & Pesticides
5.1.5 Increased Availability of Processed, Packaged and Artificial Goods
5.2 Challenges
5.2.1 Lack of Treatment Availability
5.2.2 Huge Costs
5.2.3 Lack of Investor Confidence
5.2.4 Fear of Exposure to Allergen
5.2.5 Lack of Awareness
5.2.6 Anaphylaxis
5.2.7 Length and Inconvenience Associated with Treatments
Table A: Length and Inconvenience Associated with Treatments
5.3 Market Trends
5.3.1 Evaluation of Current Allergy Treatments
Table B: Evaluation of Current Allergy Treatments
5.3.2 Increasing Innovation
Table C: Circassia Ultra-Short Course Subcutaneous Immunotherapy Segment
5.3.3 Innovations in HDM
5.3.4 FDA Approval for Peanut Allergy
6. Competitive Landscape
6.1 Global Competitive Landscape
6.1.1 Global Allergy Immunotherapy Market Players by Share
Table 27: Global Allergy Immunotherapy Market Players by Share; 2014 Percentage (%)
6.1.2 Global Allergy Immunotherapy Market Players by Product Development Stage
Table D: Global Allergy Immunotherapy Market Players by Product Development Stage
6.1.3 Global Allergy Immunotherapy Market Players by Treatment Course Duration
Table E: Global Allergy Immunotherapy Market Players by Treatment Course Duration
6.1.4 Global Allergy Immunotherapy Market Players by Subcutaneous Immunotherapy Products for Grass Pollen Rhinitis
Table F: Global Allergy Immunotherapy Market Players by Subcutaneous Immunotherapy Products for Grass Pollen Rhinitis
6.2 Regional Competitive Landscape
6.2.1 Europe Allergy Immunotherapy Market Players by Share
Table 28: Europe Allergy Immunotherapy Market Players by Share; 2014 (Percentage, %)
6.2.2 US Allergy Immunotherapy Market Players by Share
Table 29: US Allergy Immunotherapy Market Players by Share; 2014 (Percentage, %)
7. Company Profile
7.1 Allergy Therapeutics plc
7.1.1 Business Overview
7.1.2 Financial Overview
Table 30: Allergy Therapeutics Revenue; 2012-2016 (US$ Million)
Table 31: Allergy Therapeutics Revenue by Region; 2016
7.1.3 Business Strategy
7.2 ALK-Abello
7.2.1 Business Overview
7.2.2 Financial Overview
Table 32: ALK-Abello Revenue; 2011-2015 (US$ Million)
Table 33: ALK-Abello Revenue by Product Line; 2015
7.2.3 Business Strategy
7.3 Merck Group
7.3.1 Business Overview
7.3.2 Financial Overview
Table 34: Merck Group Net Sales; 2011-2015 (US$ Billion)
Table 35: Merck Group Net Sales by Business Sector; 2015
7.3.3 Business Strategy
7.4 Stallergenes
7.4.1 Business Overview
Table 36: Stallergenes Product Portfolio
7.4.2 Financial Overview
Table 37: Stallergenes Net Sales; 2011-2015 (US$ Million)
Table 38: Stallergenes Net Sales by Product Type; 2015
7.4.3 Business Strategy

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook